Skip to main navigation Skip to search Skip to main content

‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

  • The REGAIN study group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1991-2001
Number of pages11
JournalJournal of Neurology
Volume267
Issue number7
DOIs
StatePublished - Jul 1 2020

ASJC Scopus Subject Areas

  • Neurology
  • Clinical Neurology

Keywords

  • Acetylcholine receptor
  • Eculizumab
  • Minimal symptom expression
  • Myasthenia gravis
  • Refractory

Cite this